Compare · BBLG vs ISRG
BBLG vs ISRG
Side-by-side comparison of Bone Biologics Corp (BBLG) and Intuitive Surgical Inc. (ISRG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BBLG and ISRG operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ISRG is the larger of the two at $170.78B, about 69949.1x BBLG ($2.4M).
- Over the past year, BBLG is down 66.1% and ISRG is down 6.3% - ISRG leads by 59.9 points.
- ISRG has hit the wire 4 times in the past 4 weeks while BBLG has been quiet.
- ISRG has more recent analyst coverage (25 ratings vs 0 for BBLG).
- Company
- Bone Biologics Corp
- Intuitive Surgical Inc.
- Price
- $1.40+0.72%
- $482.17+0.68%
- Market cap
- $2.4M
- $170.78B
- 1M return
- +21.74%
- +2.61%
- 1Y return
- -66.13%
- -6.26%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2000
- News (4w)
- 0
- 4
- Recent ratings
- 0
- 25
Bone Biologics Corp
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Intuitive Surgical Inc.
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Latest BBLG
- Bone Biologics Corp filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 424B5 filed by Bone Biologics Corp
- SEC Form 10-K filed by Bone Biologics Corp
- SEC Form 4 filed by Chief Financial Officer Walsh Deina H
- SEC Form 4 filed by Chief Executive Officer Frelick Jeff
- Bone Biologics Corp filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
- Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months
- SEC Form 10-Q filed by Bone Biologics Corp
- SEC Form S-8 filed by Bone Biologics Corp
Latest ISRG
- SEC Form 10-Q filed by Intuitive Surgical Inc.
- Intuitive Announces First Quarter Earnings
- Intuitive Surgical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- The Infrastructure Play Hiding in Plain Sight Across Cardiac Care
- Amendment: SEC Form SCHEDULE 13G/A filed by Intuitive Surgical Inc.
- Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems
- SEC Form DEFA14A filed by Intuitive Surgical Inc.
- SEC Form DEF 14A filed by Intuitive Surgical Inc.
- EVP & Chief Medical Officer Curet Myriam exercised 105 shares at a strike of $229.39 and sold $51,865 worth of shares (105 units at $493.95) (SEC Form 4)
- Intuitive Surgical upgraded by Citigroup with a new price target